These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7625006)

  • 21. An evaluation and improvement program for inpatient anticoagulant control.
    Phillips WS; Smith J; Greaves M; Preston FE; Channer KS
    Thromb Haemost; 1997 Feb; 77(2):283-8. PubMed ID: 9157582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Potentials of infusion therapy in enhancing the detoxification effect of hemosorption in patients suffering from suppurative-septic complications of mechanical injury].
    Deriabin II; Trusov AA; Rozhkov AS; Shashkov BV; Gard IS
    Vestn Khir Im I I Grek; 1987 Jan; 138(1):87-90. PubMed ID: 3590549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extracorporeal heparinization during hemosorption].
    Pavlovskiĭ MP; Orel GL; Mazur IuI
    Klin Khir (1962); 1988; (3):76-7. PubMed ID: 3404851
    [No Abstract]   [Full Text] [Related]  

  • 24. Limits of APTT for monitoring heparin.
    Vine DL
    Kans Med; 1993 Jan; 94(1):23-4. PubMed ID: 8433544
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin-induced platelet factor 4 release by serial heparin injections.
    Stevanato F; Paolini R; Sgarbossa G; Simioni P; Cella G
    J Nucl Med Allied Sci; 1988; 32(2):106-9. PubMed ID: 3171705
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlling anticoagulation in extracorporeal blood circuits (hemoperfusion).
    Mor L; Sideman S; Mihich M; Tzipiniuk A; Lupovich S; Brandes JM
    Int J Artif Organs; 1984 Jan; 7(1):11-21. PubMed ID: 6698630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemosorption in the combined treatment of patients with destructive pancreatitis].
    Laptev VV; Bagaudinov GM; Gaziev RM
    Khirurgiia (Mosk); 1985 Aug; (8):30-3. PubMed ID: 4057843
    [No Abstract]   [Full Text] [Related]  

  • 29. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.
    Klootwijk P; Lenderink T; Meij S; Boersma H; Melkert R; Umans VA; Stibbe J; Müller EJ; Poortermans KJ; Deckers JW; Simoons ML
    Eur Heart J; 1999 Aug; 20(15):1101-11. PubMed ID: 10413640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term anticoagulation therapy in cervical ribs?].
    Hiller E
    Internist (Berl); 1996 Dec; 37(12):1272. PubMed ID: 9081931
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assays.
    Baker BA; Adelman MD; Smith PA; Osborn JC
    Arch Intern Med; 1997 Nov; 157(21):2475-9. PubMed ID: 9385299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.
    Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J;
    Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin toxicity following allogeneic bone marrow infusion.
    Williamson MJ; Kudva GC; Pincus SM
    Bone Marrow Transplant; 2008 Mar; 41(6):585-6. PubMed ID: 18026142
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood coagulation potential in patients with mechanical jaundice during hemosorption].
    Lekhtman AM; Iunovidova LI; Levantovskaia OM
    Sov Med; 1990; (2):65-7. PubMed ID: 2356532
    [No Abstract]   [Full Text] [Related]  

  • 37. Bleeding and thrombosis in high-risk renal transplantation candidates using heparin.
    Mathis AS; Davé N; Shah NK; Friedman GS
    Ann Pharmacother; 2004 Apr; 38(4):537-43. PubMed ID: 14766999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemosorption in experiments on mice].
    Gutsenko KK; Nesterova TA; Chertkov KS
    Patol Fiziol Eksp Ter; 1982; (2):79-81. PubMed ID: 7088591
    [No Abstract]   [Full Text] [Related]  

  • 39. [Quantitative determination of heparin in the blood during hemosorption].
    Efimov VS
    Anesteziol Reanimatol; 1982; (6):46-9. PubMed ID: 7158844
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemosorption in the combined treatment of patients with acute exogenous poisonings].
    Kurashov OV; Treshchinskiĭ AI; Trotsevich VA
    Vrach Delo; 1991 Jul; (7):74-6. PubMed ID: 1771843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.